ALLIANCE A031702Primary Category:Treatment ProtocolsDisease Category:Bladder, Genitourinary, Prostate, RenalStatus:OpenA Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)(Click for More Info)NCT#03866382